NextFin News - Unitree Robotics, the world's top-shipping humanoid robot maker, opened 629% above its IPO price in its Shanghai trading debut on Wednesday, a more than 600% first-day pop that hands China its first onshore-listed pure-play humanoid stock and gives the sector a public-market price tag for the first time. The Hangzhou-based company's shares opened at 1,100 yuan on the tech-focused STAR Market, versus an offer price of 150.8 yuan set just days earlier, lifting its market value to roughly 445 billion yuan at the open. The debut landed on the opening day of the World Robot Conference in Beijing, where founder Wang Xingxing was scheduled to address the main forum on the next decade of the humanoid industry.
The rally is a verdict less on Unitree's earnings than on how badly investors want a flagship Chinese artificial-intelligence hardware name. It also marks the moment a sector that has been valued behind closed doors — in private rounds at 10 billion, 15 billion, 20 billion yuan, depending on the room — finally meets the discipline of a public price.
The Mechanics of a 600% Open
The first-order explanation is mechanical. Unitree raised 6.1 billion yuan ($905 million) last week by selling 40.45 million new shares, or 10% of its enlarged capital, at 150.8 yuan each — a valuation of about 61 billion yuan ($9.04 billion). Retail demand ran to more than 8,000 times the shares on offer, a record for Shanghai's STAR Market, leaving winning subscribers with an allocation rate of just 0.018%. At the open, only 30.09 million unrestricted shares were tradable — 7.44% of the post-listing total — meaning 92.56% of the register was locked up.
That structure is a recipe for violent first prints. A tiny float met the largest retail stampede in the board's history, and there was no circuit breaker to contain it. Unlike the Shanghai main board, where first-day gains for new listings are capped at 44%, the STAR Market imposes no price ceiling on debut day. The same mechanism produced ChangXin Memory Technologies' 466% surge in late July, when the chipmaker closed at 49 yuan against an offer price of 8.66 yuan to become China's most valuable listed company.
The timing was also deliberate. Unitree's listing coincided with the opening of the World Robot Conference, which Beijing authorities say is drawing more than 300 companies, over 2,000 exhibits, and more than 150 product launches. The World Humanoid Robot Games — combining races, football, and fighting with factory, hotel, and household task trials — run from 22 to 26 August at the National Speed Skating Oval. A stock debut and a national industry showcase on the same week is not coincidence; it is staging.
A Profitable Unicorn in a Sector of Losses
What separates Unitree from the typical pre-revenue tech listing is that it actually makes money. Its prospectus showed 2025 revenue of 1.708 billion yuan, up 335% year on year, with humanoids overtaking the company's robot dogs as the largest business in the first nine months of the year. It reported attributable net profit of 278.2 million yuan and a gross margin of 60.27%. It shipped 5,511 humanoid units in 2025, a more than tenfold jump from 2024, giving it a 32.4% share of global humanoid unit shipments — the top position worldwide. Since its founding it has sold more than 33,000 robot dogs.
Contrast that with UBTECH, the Hong Kong-listed company often called the sector's first public name. UBTECH reported 2025 revenue of 2.01 billion yuan, up 53.3%, but posted a net loss of 790 million yuan and a gross margin of 37.7%, with humanoid sales of 1,079 units. Unitree, by comparison, is smaller in revenue but profitable, with roughly five times the humanoid shipment volume and a gross margin 22 percentage points higher.
That profitability is the core of the bull case. In a capital-intensive hardware race where most rivals are burning cash, Unitree has shown it can cut prices, ship volume, and still keep 60% of every yuan of revenue. The company's average selling price for humanoids fell from 590,000 yuan to 166,400 yuan — a 72% decline — as it pushed from lab-grade machines toward mass-market products such as the G1, which retails from $13,500. Volume is the strategy: ship more, cheaper, and defend margin with scale and vertical integration. Unitree produces its own actuators and has driven robot-dog prices from $45,000 to under $2,000 over six years.
Yet the valuation math is unforgiving. The 150.8 yuan offer price already implied a price-earnings ratio of 219.23 times 2025 earnings, nearly six times the 38.56-times average of the general equipment manufacturing industry. At Wednesday's 1,100-yuan open, the market was pricing the company at roughly 1,600 times trailing earnings. The question is no longer whether Unitree is a good company — it is whether the world's most expensive robot stock can grow into a price that assumes perfection.
The Earnings Crack the Rally Is Ignoring
The near-term trajectory is already bending. In the first quarter of 2026, Unitree's revenue grew 68.5% year on year to 422.8 million yuan, but net profit fell 52.6% to 40.3 million yuan as the company increased spending on research and marketing. The prospectus warned that the company may cut humanoid selling prices further to cope with rising competition. The average selling price decline is the evidence that the price war is already underway.
There is also a margin tension worth watching. Third-party teardown analysis cited by industry observers estimates the bill of materials for the G1 at under $9,000, implying a gross margin closer to 33% on that model — well below the company's 60.27% blended margin. The gap is explained by the mix: robot dogs and components, which still accounted for 42.25% of revenue in the first nine months of 2025, carry different economics than the entry-level humanoid. But as humanoids become the dominant line and the cheapest models drive volume, the blended margin has nowhere to go but down unless scale offsets it.
The counter-argument is that this is the normal shape of a platform company's early curve. Robot dogs have been the cash engine; humanoids are the growth engine. If humanoids follow the dog's path — steep price cuts, followed by volume expansion, followed by margin stabilization — the 52.6% profit dip is a speed bump, not a breakdown. Platform economics reward the company that reaches scale first, and Unitree's five-thousand-unit lead is meaningful in a market that shipped only tens of thousands of humanoids in total last year.
The Second-Order Story: A Benchmark for Every Rival
The first-order story is a small float and a big pop. The second-order story is what the listing does to the rest of the sector. Before Unitree priced, valuations for Chinese humanoid makers were private, inconsistent, and untested. A public price now exists: 61 billion yuan at the offer, and whatever the market decides from here. That anchor will flow into every pending deal.
"It gives mainland investors direct exposure to one of the sector's leading companies and could influence valuations for future robotics IPOs and private companies." — Kangyuxiao Li, analyst at Morningstar
The queue behind Unitree is long. UBTECH and Dobot already trade in Hong Kong; Agibot, another frontrunner, is pursuing a Hong Kong IPO. Unitree's multiple becomes the reference point against which each of them will be measured — and the bar is now set at a 219-times earnings entry price. For UBTECH, still loss-making, the comparison is unflattering. For Agibot, the comparison is a fundraising windfall if it can reach market before sentiment turns. The benchmark effect is the real structural consequence of this debut: Unitree has not just priced its own shares, it has priced the sector.
DeepSeek, the Chinese AI startup, is among the strategic investors in the IPO, according to the filing — a signal that the humanoid race is being treated as an extension of the AI infrastructure buildout, not merely a hardware story. CITIC Securities served as sponsor and lead underwriter. The China Securities Regulatory Commission approved the listing in early July; from the Shanghai Stock Exchange's acceptance of the application on 20 March to registration, the full review cycle took 104 days, which the company says is the fastest end-to-end process in STAR Market history.
The Geopolitical Overhang
There is a third force in the valuation, and it points the other way. Days before Unitree opened subscriptions, the United States added foreign-made humanoid and quadruped robots to its restricted list, effectively barring new imports. Unitree said its existing models have U.S. approvals, but future models could be barred from sale there. The company has not disclosed how much revenue comes from the United States, so the exposure is unquantified — which is precisely the risk investors are choosing to ignore.
This is the Sino-U.S. technology contest in miniature: a Chinese champion in a dual-use technology, celebrated at home, restricted abroad. The listing was framed by some as a watershed moment for China's robotics sector — a key battleground in the tech war. A company priced at 219 times earnings cannot afford an unmeasured hole in its largest potential export market, and the restricted list is a live variable, not a one-time event.
The Strongest Counter-Thesis
The bullish case is not hard to state, and it deserves its full weight. Unitree is the only profitable, scaled humanoid maker with a public price. It leads global shipments with a third of the market. It holds a 60% gross margin in a hardware business. It is led by a founder who controls 68.78% of voting rights and can execute without shareholder friction. China built the deep supply chain — motors, gearboxes, batteries, actuators — that makes rapid cost reduction possible, and it has written embodied intelligence into national policy. If humanoid robots are the next consumer-electronics category, Unitree is the early Sony, and today's multiple is tomorrow's discount.
The flaw in that argument is timing, not direction. Even if the long-term thesis is right, the stock is pricing a decade of success into a company whose profit just fell 52.6% in a quarter. The gap between a correct structural call and a correct entry price is where investors lose money. A 1,600-times earnings multiple leaves no margin for error: any stumble in revenue growth, any acceleration in price cuts, any hardening of export restrictions becomes a de-rating event rather than a buying opportunity.
The falsifying signal is concrete. If Unitree's next quarterly report shows humanoid gross margin falling below 50% while revenue growth slows below 40%, the scale-before-profit story is failing and the multiple has no anchor. A second signal: if the company discloses that U.S. restrictions have cut overseas revenue materially, the export-growth pillar of the valuation collapses. Either one would convert today's structural narrative into a cyclical trap.
What to Watch
The outlook splits cleanly across three horizons.
In the short term, the stock will be driven by liquidity and sentiment, not fundamentals. With 92.56% of shares locked up, the price can stay dislocated from earnings for longer than a discounted-cash-flow model would allow. Watch the first-week turnover and whether the price holds above the 1,100-yuan open. A break below the opening level on heavy volume would signal the speculative leg is exhausting itself.
In the medium term, the earnings trajectory decides. The base case is continued revenue growth above 50% with margin pressure as price competition intensifies. The upside case is that humanoids scale fast enough to offset price cuts, keeping gross margin above 55% and restoring profit growth. The downside case is a margin collapse below 50% alongside slowing revenue — the exact combination that would break the valuation.
In the long term, the structural call stands: humanoid robotics is being industrialized, and China is building the supply chain and policy scaffolding to lead it. Unitree's listing gives the sector a public benchmark, and that benchmark will lift or sink every robotics IPO that follows. Agibot's pending Hong Kong listing is the next test of whether this is a durable repricing or a one-day mania.
The closing judgment: Unitree's 600%-plus debut is less a verdict on the company than a verdict on how badly investors want a China AI-hardware champion. The robot can do backflips. The question is whether the stock can do anything but fall back to earth.
Explore more exclusive insights at nextfin.ai.
